William Blair Resumes Jasper Therapeutics (JSPR) at Outperform
Tweet Send to a Friend
(Updated - October 14, 2026 5:44 AM EDT)
William Blair analyst Matt Phipps resumes coverage on Jasper Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Matt Phipps resumes coverage on Jasper Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




